Yi Zhao

1.6k citations
71 papers · 1.1k indexed · 1 hit paper · h-index 19
Topics
Cancer Immunotherapy and Biomarkers (9 papers)Cancer Cells and Metastasis (8 papers)Cancer Genomics and Diagnostics (5 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONECancer Research

In The Last Decade

Yi Zhao

63 papers receiving 1.1k citations

Hit Papers

Protein tyrosine kinase inhibitor resistance in malignant...2022202620232024202250100150

Peers

Yi Zhao
Comparison fields: 5 of 116
  • Molecular Biology 311
  • Oncology 304
  • Cancer Research 190
  • Pulmonary and Respiratory Medicine 159
  • Immunology 140
Replace Chao Sheng with:
Chao Sheng China
Meng Jiang China
Mustafa Ascha United States
Sebastian M. Jud Germany
Marco Carbone Italy
Sarah L. Kerns United States
Laura Boucai United States
Yang Tang China
Yi Zhao relative to Chao Sheng China Chao Sheng's profile →
Citations per field
00.5×1.5×1.8×
Chao Sheng · 1×
Citations per year

Countries citing papers authored by Yi Zhao

Since Specialization
Citations

This map shows the geographic impact of Yi Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Zhao more than expected).

Fields of papers citing papers by Yi Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Zhao. The network helps show where Yi Zhao may publish in the future.

Co-authorship network of co-authors of Yi Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Zhao. A scholar is included among the top collaborators of Yi Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Zhao. Yi Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 4
5 25
6 15
7 0
8 2
9 4
10 6
11 1
12
Resveratrol As A Natural Regulator Of Autophagy For Prevention And Treatment Of Cancer
4
13 13
14 1
15 20
16 6
17 1
18 18
19 35
20 8

About Yi Zhao

Yi Zhao is a scholar working on Biological Psychiatry, Cancer Research and Oncology, having authored 71 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Cancer Cells and Metastasis (8 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Obstetrics and Gynecology (116 citations), Health Informatics (19 citations) and Cancer Research (190 citations). Yi Zhao has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Xuelian Gao, Huixia Yang, Qiu Li, Yujiao Wang, Yang Yang, Shuo Li, Shui Wang, Qiang Ding, Wenbin Zhou and Xiaoan Liu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026